Pathway’s post-transformer architecture BDH integrated with NVIDIA AI and AWS cloud infrastructure Pathway model’s continuous learning, efficiency, and live observability is powered by NVIDIA AI ...
An EMA pilot study looking at progressive licensing of new drugs has found that there are merits to the approach, but further work is needed before the concept can be rolled out across the EU. The EMA ...
LONDON – Pluristem Therapeutics Inc.'s PLX placenta-based cell therapy has been selected for the EMA adaptive pathways pilot, a designation the company said will save a lot of money and cut three to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback